---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-007479"
form_type: "8-K/A"
ticker: "ZIVO"
cik: "0001101026"
company_name: "Zivo Bioscience, Inc."
filed_at: "2024-06-07T23:59:59+00:00"
generated_at: "2026-06-01T05:28:19.945500+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Zivo Bioscience amends 8-K to correct date typo in director stock award from 2023

## Summary
- Corrects date in Item 1.01 from erroneous date to December 29, 2023.
- Board approved 261,619 shares to three non-employee directors for unpaid 2023 fees of $172,670.
- Shares issued at $1.20 per share (Dec 29, 2023 close), grossed up for taxes at 45%.
- Directors Cornell (95k), Masterson (85k), Maggiore (82k) accepted grants on June 5, 2024.

## SEC filing metadata
- accession: 0001654954-24-007479
- form_type: 8-K/A
- ticker: ZIVO
- cik: 0001101026
- company_name: Zivo Bioscience, Inc.
- filed_at: 2024-06-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1101026/000165495424007479/0001654954-24-007479-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1101026/000165495424007479/zivo_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-007479
- JSON: https://secwatch.observer/filing/0001654954-24-007479.json
- Plain text: https://secwatch.observer/filing/0001654954-24-007479.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.